Mi-Ok Kim Selected Research

Mi-Ok Kim Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 05/2008
11	Crohn Disease (Crohn's Disease) 01/2019 - 04/2009
7	Neurofibroma 02/2019 - 02/2012
5	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2010
4	Inflammation (Inflammations) 06/2014 - 05/2003
3	Squamous Cell Carcinoma of Head and Neck 11/2021 - 01/2019
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 06/2015
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 04/2009
3	Pediatric Crohn's disease 10/2017 - 09/2013
3	Fanconi Anemia (Fanconi's Anemia) 01/2014 - 08/2007
3	Ileal Diseases 09/2013 - 05/2011
3	Hypersensitivity (Allergy) 05/2009 - 06/2008
2	Plexiform Neurofibroma 01/2021 - 02/2012
2	Fibrosis (Cirrhosis) 01/2019 - 01/2016
2	Albuminuria 01/2019 - 07/2011
2	Pathologic Constriction (Stenosis) 01/2019 - 09/2013
2	Ulcerative Colitis 01/2018 - 07/2013
2	Bone Marrow Failure Disorders 01/2014 - 08/2007
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2013 - 12/2010
2	Neurofibrosarcoma (MPNST) 01/2013 - 05/2008
2	Brain Injuries (Brain Injury) 01/2003 - 10/2002
2	Astrocytoma (Pilocytic Astrocytoma) 01/2003 - 10/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Residual Neoplasm 01/2022
1	Pressure Ulcer (Bedsore) 11/2021
1	Leukemia 11/2021
1	Delayed Graft Function 10/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Dysbiosis 01/2019
1	Carcinogenesis 03/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2015
1	Hypertrophy 06/2015
1	Type I Syndactyly 06/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2021 - 10/2002
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018 - 04/2009
5	AutoantibodiesIBA 01/2018 - 04/2009
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2011
3	Everolimus FDA Link 11/2013 - 05/2008
2	Tyrosine Kinase InhibitorsIBA 11/2021 - 05/2008
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 04/2009
2	mirdametinibIBA 10/2015 - 01/2013
2	Pharmaceutical PreparationsIBA 10/2015 - 02/2012
2	Messenger RNA (mRNA)IBA 06/2015 - 10/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014 - 05/2009
2	EquolIBA 11/2010 - 05/2010
2	Growth Hormone (Somatotropin)IBA 08/2010 - 08/2007
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/2008 - 06/2008
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2003 - 10/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2003 - 10/2002
1	Hormones (Hormone)IBA 01/2022
1	AlpelisibIBA 11/2021
1	Cetuximab (Erbitux)FDA Link 11/2021
1	Immune Checkpoint ProteinsIBA 11/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2021
1	Cisplatin (Platino)FDA LinkGeneric 11/2021
1	Saline SolutionIBA 10/2021
1	Peptide Nucleic AcidsIBA 01/2021
1	Chemokine CXCL10IBA 02/2019
1	CXCR3 ReceptorsIBA 02/2019
1	ElementsIBA 01/2019
1	Cartilage Oligomeric Matrix ProteinIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	Collagen Type III (Type III Collagen)IBA 01/2019
1	EnzymesIBA 01/2019
1	CytokinesIBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	FLLL 32IBA 01/2019
1	alpha-DefensinsIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	AntibodiesIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 10/2017
1	N-acetyltalosaminuronic acid (NAT)IBA 08/2017
1	Histones (Histone)IBA 03/2016
1	CateninsIBA 03/2016
1	Infliximab (Remicade)FDA Link 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	Guanosine Triphosphate (GTP)IBA 10/2015
1	ras GTPase-Activating Proteins (ras-GAP)IBA 10/2015
1	AdiponectinIBA 06/2015
1	Oxidoreductases (Dehydrogenase)IBA 06/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2015
1	Mitochondrial DNA (mtDNA)IBA 06/2015
1	Immunologic Factors (Immunomodulators)IBA 02/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014

Therapy/Procedure

12	Therapeutics 02/2019 - 05/2008
3	Neoadjuvant Therapy 01/2022 - 01/2017
3	Cell Transplantation 11/2013 - 12/2010
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Time-to-Treatment 08/2017 - 01/2017
2	Transplantation 03/2016 - 02/2013
1	Critical Care (Surgical Intensive Care) 11/2021
1	Phototherapy (Light Therapy) 11/2021
1	Perioperative Period 10/2021
1	Kidney Transplantation 10/2021
1	Treatment Delay 08/2017
1	Secondary Prevention 02/2014